Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Zoetis Inc. NYSE:ZTS Shares Sold by ProShare Advisors LLC

May 28, 2025
ProShare Advisors LLC recently sold a significant number of shares in Zoetis Inc. (NYSE: ZTS), indicating a change in their investment strategy. Zoetis Inc. is a global animal health company that develops and produces a wide range of veterinary vaccines and medicines. This move by ProShare Advisors LLC may have implications for the future performance of Zoetis stock, so investors should keep an eye on the company's latest developments. For a more accurate forecast of Zoetis Inc. NYSE:ZTS stock movement, consult professionals from Stocks Prognosis.

Find out how the ZOETIS INC. rate is expected to change

Get Forecast for ZTS

Investor opinions & comments:

Zoetis has a strong track record in the animal health sector, so I'm not too concerned about this sell-off
— from SavannahGordon at 05-31-2025 04:11
I see this as an opportunity to potentially buy Zoetis stock at a lower price before it rebounds
— from DavidWilson at 05-29-2025 10:49
I wonder what other factors may have influenced ProShare Advisors LLC's decision to sell Zoetis shares
— from TraderTina at 05-29-2025 07:32
It's always important to monitor changes in major investors' strategies for insights into stock performance
— from KatherineSanchez at 05-29-2025 02:53
This could be a signal of potential future trends in the animal health industry
— from OwenSullivan at 05-28-2025 08:38
If you want to leave a comment, then you need Login or Register





Other news for ZTS

ZTSApril 8, 2025QuantWave Achieves 12.47% Profit Target with Successful Forecast for Zoetis Inc. Stock  ~2 min.

On February 26, 2025, QuantWave, the automated forecasting platform, issued a short signal for Zoetis Inc. stock (ZTS) with a price of $164.44....

ZTSApril 8, 2025QuantWave Successfully Predicts ZOETIS INC. Stock Movement, Achieving Profit of 12.49%  ~1 min.

On March 27, 2025, QuantWave issued a short signal for ZOETIS INC. with the stock trading at 164.47 $. The forecast proved to be accurate as the price target of 143....

ZTSApril 8, 2025QuantWave Achieves 13.65% Profit Target Forecast for Zoetis Inc.  ~1 min.

QuantWave, an automated forecasting platform, successfully reached its price target forecast for Zoetis Inc., generating a profit of 13.65%....

ZTSMarch 21, 2025Zoetis Inc. Continues to Attract Investors with Xponance Inc. Acquiring 2814 Shares  ~1 min.

Zoetis Inc., a leading global animal health company, has caught the attention of investors as Xponance Inc. recently acquired 2814 shares of its stock....

ZTSMarch 20, 2025ZTS Zoetis Inc. Continues to Attract Investor Interest  ~1 min.

Zoetis Inc. (NYSE:ZTS) has been gaining attention from investors as short interest in the company continues to rise....



Related news

ZTSFebruary 28, 2025Zoetis Inc. NYSE:ZTS Reports Stronger Return on Equity than Industry  ~1 min.

Zoetis Inc., a leading animal health company, has recently announced a higher return on equity (ROE) compared to its industry peers....

ZTSJanuary 28, 2025Zoetis Inc. Continues to Outperform Industry with Strong Return on Equity  ~1 min.

Zoetis Inc., a leading global animal health company, has once again outperformed its industry peers with a better Return on Equity (ROE)....

ZTSSeptember 9, 2024QuantWave Achieves 13.28% Profit Target Forecast for Zoetis Inc.  ~1 min.

QuantWave, an automated forecasting platform, recently hit the mark with its price target forecast for Zoetis Inc. On June 18, 2024, the signal was given to go long on the stock when it was trading at $167....

ZTSFebruary 26, 2025Zoetis Inc. NYSE:ZTS Achieves Remarkable ROE, Outperforming Industry Peers  ~2 min.

Zoetis Inc., a leading global animal health company, has recently reported a higher return on equity (ROE) compared to its industry counterparts....

ZTSFebruary 3, 2025Zoetis Inc. NYSE:ZTS Continues to Expand Its Market Presence  ~2 min.

Pharmaceutical company Zoetis Inc (NYSE:ZTS) has been making significant strides in the animal health industry....